Meanwhile, it has been reported that the UCHL5 inhibitor b-AP15 suppresses bladder cancer stemness by inhibiting the β-catenin and c-Myc signaling pathways and overcomes cisplatin resistance (125). The gene discussed is UCHL5; the disease is urinary bladder carcinoma.